SANTA CLARA, Calif., June 20 /PRNewswire/ -- OptiMedica(R) Corp. announced today that the Pascal Photocoagulator is a gold medal recipient of the 2007 Medical Design Excellence Award. This prestigious design award distinguishes the Pascal(R) Photocoagulator as an innovative, high quality medical product.
(Photo: http://www.newscom.com/cgi-bin/prnh/20070620/AQW061)
“OptiMedica is honored to be named a gold winner in the surgical equipment and instruments category alongside industry leaders Johnson & Johnson, Medtronic, and Stryker Instruments,” stated George Marcellino PhD, Vice President. “In over 100 award winners from the last 5 years, only 4 ophthalmic devices have received the award. OptiMedica is extremely pleased to be recognized in this elite community for advances in treating vision-threatening diseases through enhanced patient care.”
OptiMedica received the 2007 Medical Design Excellence Gold Award at the Medical Design & Manufacturing East Conference and Exposition in New York City. The Medical Design Excellence Awards, a worldwide competition, is the premier awards program for the medical technology community. It is organized and presented by Los Angeles-based Canon Communications LLC. Winning entries are chosen on the basis of design and engineering features that enhance the ability of medical professionals to provide healthcare, offer improved patient benefits, and enable better delivery of care.
Marcellino added, “The award validates OptiMedica’s efforts to build a team of innovators beyond our walls to include Texas-based supplier National Instruments Corp, and San Francisco-based designers Out of the Blue Design and RSID Studio.”
About MDEA
The Medical Design Excellence Awards competition is organized and presented by Canon Communications LLC, a Los Angeles-based medical technology publisher. Entries are evaluated on their design and engineering features, including innovative use of materials, user-related functions that improve healthcare delivery and change traditional medical attitudes or practices, features that provide enhanced benefits to the patient, and the ability of the product development team to overcome design and engineering challenges so that the product meets its clinical objectives. A comprehensive review of the entries was performed by an impartial, multidisciplinary panel of third-party jurors with expertise in biomedical engineering, human factors, industrial design, medicine, and diagnostics.
About OptiMedica Corp
OptiMedica Corp. develops and markets performance driven ophthalmic technologies focused on improving patient outcomes. OptiMedica holds the exclusive license to the Pascal(R) (PAttern SCAn Laser) method of photocoagulation and its associated technologies, which are FDA approved to treat a variety of retinal conditions. Silicon Valley-based OptiMedica was founded in 2004 in Santa Clara, Calif. and is funded by Kleiner Perkins Caufield & Byers and Alloy Ventures.
Photo: NewsCom: http://www.newscom.com/cgi-bin/prnh/20070620/AQW061AP Archive: http://photoarchive.ap.orgAP PhotoExpress Network: PRN4PRN Photo Desk, photodesk@prnewswire.comOptiMedica Corp.
CONTACT: George Marcellino, Ph.D, Vice President of OptiMedica Corp.,+1-408-850-8600
Web site: http://www.optimedica.com/
